BioCentury
ARTICLE | Financial News

Cancer Genetics again amends IPO

March 5, 2013 2:12 AM UTC

Cancer Genetics Inc. (Rutherford, N.J.) again amended its IPO and now plans to sell 1.9 million shares at $10-$12. An $11 price would raise $20.4 million and value the cancer diagnostics company at $5...